idebenone has been researched along with Parkinson Disease, Secondary in 1 studies
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
Excerpt | Relevance | Reference |
---|---|---|
"Idebenone is an analog of the well-known antioxidant compound coenzyme Q10 (CoQ10)." | 1.62 | Idebenone Ameliorates Rotenone-Induced Parkinson's Disease in Rats Through Decreasing Lipid Peroxidation. ( Avcı, B; Bilge, SS; Günaydın, C; Güvenç, T; Kuruca, N; Yavuz, CK, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Avcı, B | 1 |
Günaydın, C | 1 |
Güvenç, T | 1 |
Yavuz, CK | 1 |
Kuruca, N | 1 |
Bilge, SS | 1 |
1 other study available for idebenone and Parkinson Disease, Secondary
Article | Year |
---|---|
Idebenone Ameliorates Rotenone-Induced Parkinson's Disease in Rats Through Decreasing Lipid Peroxidation.
Topics: Animals; Antioxidants; Brain; Dopaminergic Neurons; Lipid Peroxidation; Locomotion; Male; Neuroprote | 2021 |